Ticker Details
DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date:	April 14, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$34.85B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.87 | 2.19%
Avg Daily Range (30 D):	$1.79 | 2.26%
Avg Daily Range (90 D):	$1.50 | 2.11%

Institutional Daily Volume
Avg Daily Volume:	1.14M
Avg Daily Volume (30 D):	3.99M
Avg Daily Volume (90 D):	4.14M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	21,803
Avg Institutional Trade:	$7.34M
Avg Institutional Trade (30 D):	$9.33M
Avg Institutional Trade (90 D):	$9.09M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$26.08M
Avg Closing Trade (30 D):	$72.49M
Avg Closing Trade (90 D):	$75.67M
Avg Closing Volume:	381.41K

News

Jul 14, 2026 @ 4:30 AM Global Blood Glucose Monitoring System Market Size... Source: Custom Market Insights

Jun 18, 2026 @ 3:41 PM 3 Stocks Doing the Heavy Lifting in Healthcareââ‚... Source: Jessica Mitacek

Jun 15, 2026 @ 5:02 PM Dexcom Scores Pediatric Expansion For OTC Stelo Gl... Source: Vandana Singh

Jun 4, 2026 @ 5:53 PM [Latest] Non-Invasive Blood Glucose Monitoring Dev... Source: Zion Market Research

May 15, 2026 @ 5:41 PM Diabetes Tech Player DexCom Lays Out 2030 Growth V... Source: Vandana Singh

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$2.59	$.65	$.52
Diluted EPS	$2.52	$.64	$.51
Revenue	$4.97B	$1.31B	$1.19B
Gross Profit	$3.1B	$830M	$750.3M
Net Income / Loss	$999.7M	$249.1M	$199.5M
Operating Income / Loss	$1.14B	$318.3M	$255.3M
Cost of Revenue	$1.86B	$478.4M	$441.6M
Net Cash Flow	$-55.1M
PE Ratio

Splits
Jun 13, 2022	4:1